Are GLP-1 drugs prescribed for weight loss becoming too outsized a line item for continued coverage through the state Medicaid program? That’s what Gov. Dan McKee’s fiscal year 2027 budget suggests.

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

A new study reveals stopping GLP-1 weight loss drugs leads to rapid weight regain, nearly four times faster than quitting ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. ON THIS PAGE Featured Partner While Ozempic has been ...

The weight-loss drug Wegovy is now being sold in pill form, an advancement that allows users to transition away from weekly injections. It's the first GLP-1 weight-loss medication to become available ...

As the popularity of weight-loss drugs continues to boom, it has opened the door for scammers eager to dupe people into ...

Credit: Getty Images By reinforcing the essential role of exercise, health care providers can ensure that GLP-1 therapy leads to weight loss, sustains muscle mass, and improves functional health.

GLP-1 medications have dominated the weight-loss landscape this year — but some older Americans are reportedly kicking the trend to the curb. A study published in JAMA in January 2025 — which looked ...

Weight loss drugs have shown impressive short-term results, but new research suggests their benefits may be difficult to sustain once treatment ends. Stopping treatment with weight loss medications is ...

When HCA Healthcare, one of the largest hospital systems in the U.S., recently told employees it would stop covering blockbuster obesity drugs Zepbound and Wegovy next year, it pointed them to an ...